Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of 3:59pm ET
 +0.16 / +0.38%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

No recent news for SPDR® S&P Pharmaceuticals ETF.


1 month+4.68% 3 years-3.77%
3 months+0.29% 5 years+10.31%
1 year-7.92% Since inception+11.55%
Data through 09/21/2017

Quote Details

Previous close$42.20
Open day’s range42.08 – 42.65
Net asset value (NAV)42.21 (09/20/2017)
Daily volume46,186
Average volume (3 months)87,913
Data as of 3:59pm ET, 09/21/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+10.31%+17.39%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.621.13
Net assets$450.5M$3.1B
Average market cap$8.7B$32.0B
Average P/E27.222.7
Dividend / Share--0.28%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
HZNP Horizon Pharma PLC5.08%
BMY Bristol-Myers Squibb4.92%
PRGO Perrigo Company PLC4.83%
PFE Pfizer4.52%
MNK Mallinckrodt Plc4.46%
JNJ Johnson & Johnson4.40%
LLY Eli Lilly and Co4.38%
ZTS Zoetis Inc4.38%
MRK Merck4.33%
AKRX Akorn Inc4.33%